import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰å…¨æ™¯åœ– (2026 æœ€çµ‚å…¨åŠŸèƒ½æ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === æ¥µè‡´ç·Šç·»åŒ– UI === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 30px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé«˜åº¦è‡ªé©æ‡‰ï¼Œé›¶ç•™ç™½ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent; background: white; 
        margin-bottom: 4px; overflow: hidden; height: auto !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center;
    }

    .sub-block {
        margin: 2px 4px; padding: 4px;
        border-radius: 6px; background: #F8F9FA;
        border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 13px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
    }

    /* éšæ®µé…è‰² */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 11px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="Eli Lilly"] { background: #FCE4EC !important; border-left: 5px solid #E91E63 !important; } 
    .stPopover button[aria-label*="Daiichi Sankyo"] { background: #E8F5E9 !important; border-left: 5px solid #4CAF50 !important; } 
    .stPopover button[aria-label*="MSD"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; } 
    .stPopover button[aria-label*="AstraZeneca"] { background: #F3E5F5 !important; border-left: 5px solid #8E24AA !important; } 
    .stPopover button[aria-label*="GSK"] { background: #FFF3E0 !important; border-left: 5px solid #F57C00 !important; } 
    .stPopover button[aria-label*="Gilead"] { background: #E1F5FE !important; border-left: 5px solid #03A9F4 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 42px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªï¼šPSOC/PROC åˆ†æµèˆ‡ MOC å›æ­¸ ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "MMRd / MSI-H", "content": "é¦–é¸ï¼šChemo + PD-1 (GY018/RUBY)ã€‚"},
            {"title": "NSMP / pMMR", "content": "æ’é™¤åˆ†å‹ã€‚è¦– ER/Grade æ±ºç­–ï¼›äºŒç·š Pembro+Lenvaã€‚"},
            {"title": "POLEmut / p53abn", "content": "POLE: æœ€ä½³é å¾Œï¼›p53: æœ€å·®éœ€ç©æ¥µåŒ–æ”¾ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "1L IO å¾ŒçºŒç”¨ç¶­æŒè‡³é€²å±•ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "äºŒç·šæ¨™é¶+å…ç–« (pMMR) æˆ–å–®è—¥ IO (MMRd)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "æŒçºŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ° PDã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "Surgery + Carbo/Pacli Â± Bevã€‚"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "CK7+/SATB2-ã€‚1. Expansile: é å¾Œä½³ã€‚ 2. Infiltrative: æ˜“è½‰ç§»å»ºè­°åŒ–ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥ç¶­æŒã€‚"}, {"title": "HRD positive (wt)", "content": "Olaparib+Bev æˆ– Niraparibã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive)", "content": "PFI > 6mã€‚å«é‰‘é›™è—¥ Â± Bevã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ã€‚"},
            {"title": "PROC (Resistant)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive Maint", "content": "å«é‰‘æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Locally Advanced (CCRT)", "content": "CCRT Â± åŒæ­¥ IO (A18) æˆ–èª˜å°åŒ–ç™‚ã€‚"},
            {"title": "Early Stage (Surgery)", "content": "é–‹è…¹æ ¹æ²»è¡“ (LACC) æˆ–å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic Maint", "content": "1L IO æ–¹æ¡ˆå¾Œæ¥çºŒç¶­æŒã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "Recurr / Metastatic", "content": "ä¸€ç·š Pembro+åŒ–ç™‚Â±Bevã€‚äºŒç·š ADC (Tivdak)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒç•¶å‰æœ‰æ•ˆæ–¹æ¡ˆç›´åˆ°é€²å±•ã€‚"}]}
    ]
}

# --- 2. å¯¦è­‰é‡Œç¨‹ç¢‘ (ğŸ“š Milestone - æ¤å…¥ Survival æ•¸æ“š) ---
milestone_db = [
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H"], "name": "ğŸ“š RUBY (Dostarlimab)", "type": "Published", "drug": "Dostarlimab + CP", 
     "summary": "ä¸€ç·šæ™šæœŸ/å¾©ç™¼ã€‚dMMR æ­»äº¡é¢¨éšªé™ 68% (HR 0.32)ï¼›å…¨äººç¾¤ mOS 44.6m vs 28.2m (HR 0.69)ã€‚",
     "rationale": "é€é PD-1 é˜»æ–·é‡‹æ”¾å…ç–«åˆ¶å‹•ï¼Œå”åŒåŒ–ç™‚èª˜å°çš„æŠ—åŸæš´éœ²ï¼Œé‡å° MMRd æ—ç¾¤é”åˆ°æŒä¹…æ‡‰ç­”ã€‚",
     "regimen": "Dostarlimab 500mg Q3W + CP x6 é€±æœŸ -> ç¶­æŒ Dostarlimab 1000mg Q6W æœ€é•· 3å¹´ã€‚",
     "inclusion": ["FIGO III-IV æœŸæˆ–é¦–æ¬¡å¾©ç™¼ ECã€‚", "åŒ…å« Carcinosarcoma / Serous å‹æ…‹ã€‚", "dMMR æˆ– MSI-H ç‹€æ…‹ã€‚"],
     "results": "dMMR: HR 0.32 (PFS); å…¨äººç¾¤: mOS 44.6m (vs 28.2m)."},
    
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H", "NSMP / pMMR"], "name": "ğŸ“š NRG-GY018", "type": "Published", "drug": "Pembrolizumab + CP", 
     "summary": "ä¸€ç·šã€‚dMMR PFS HR 0.30ï¼›pMMR äº¦é¡¯è‘—æ”¹å–„ (HR 0.54)ã€‚æ”¯æŒä¸€ç·šä¸é™åˆ†å‹ IOã€‚",
     "regimen": "Pembrolizumab 200mg Q3W + CP x6 é€±æœŸ -> ç¶­æŒ 400mg Q6W æœ€é•· 2å¹´ã€‚",
     "inclusion": ["FIGO III-IV æœŸæ™šæœŸæˆ–å¾©ç™¼ ECã€‚", "å€åˆ† dMMR èˆ‡ pMMRCohortã€‚"],
     "results": "dMMR PFS HR 0.30; pMMR PFS HR 0.54."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H"], "name": "ğŸ“š AtTEnd", "type": "Published", "drug": "Atezolizumab + CP", 
     "summary": "ä¸€ç·šã€‚dMMR PFS HR 0.36ï¼›å…¨äººç¾¤ OS HR 0.82 (P=0.048)ã€‚æ”¯æŒä¸€ç·šå…ç–«è·¯å¾‘ã€‚",
     "results": "dMMR PFS HR 0.36; ITT OS HR 0.82."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775", "type": "Published", "drug": "Lenvatinib + Pembro", 
     "summary": "äºŒç·šã€‚pMMR OS 17.4m vs 12.0m (HR 0.68)ï¼›5å¹´ OS 16.7% vs 7.3%ã€‚ç¢ºç«‹ MSS æ¨™æº–ã€‚",
     "results": "pMMR OS HR 0.68; mOS 17.4m vs 12.0m."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š KEYNOTE-A18", "type": "Published", "drug": "Pembro + CCRT", 
     "summary": "LACC æ¨™æº–ã€‚36å€‹æœˆ OS é¡¯è‘—æå‡ (82.6% vs 74.8%, HR 0.67)ã€‚æ”¯æŒåŒæ­¥å…ç–«ã€‚",
     "results": "36m OS 82.6% (vs 74.8%); OS HR 0.67."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š CALLA (é™°æ€§)", "type": "Published", "drug": "Durvalumab + CCRT", 
     "summary": "å±€éƒ¨æ™šæœŸã€‚æ•´é«”æœªé”çµ±è¨ˆå­¸é¡¯è‘— PFS æ”¹å–„ (HR 0.84)ã€‚æç¤ºåˆ†æµå¿…è¦æ€§ã€‚",
     "results": "PFS HR 0.84 (P=NS)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "type": "Published", "drug": "Pembro + åŒ–ç™‚ Â± Bev", 
     "summary": "R/M ä¸€ç·šã€‚å…¨äººç¾¤ OS HR 0.63ï¼›CPSâ‰¥1 HR 0.60ã€‚å¥ å®šä¸€ç·š IO æ¨™æº–ã€‚",
     "results": "OS HR 0.63 (ITT); HR 0.60 (CPSâ‰¥1)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š BEATcc", "type": "Published", "drug": "Atezo + Chemo + Bev", 
     "summary": "R/M ä¸€ç·šã€‚PFS 13.7m vs 10.4m (HR 0.62)ï¼›OS HR 0.68ã€‚æä¾› IO æ–°é¸é …ã€‚",
     "results": "PFS HR 0.62; OS HR 0.68."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š EMPOWER-Cx 1", "type": "Published", "drug": "Cemiplimab", 
     "summary": "äºŒç·šã€‚OS 12.0m vs 8.5m (HR 0.69)ï¼›ç²ç›Šä¸ä¾è³´ PD-L1ã€‚å¾Œç·š IO åŸºçŸ³ã€‚",
     "results": "OS HR 0.69; mOS 12.0m vs 8.5m."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE Trial", "type": "Published", "drug": "Simple Hysterectomy", 
     "summary": "æ—©æœŸä½é¢¨éšªã€‚3å¹´å¾©ç™¼ç‡èˆ‡æ ¹æ²»è¡“ç›¸ç•¶ (2.5% vs 2.2%)ã€‚æ”¯æŒé™éšã€‚",
     "results": "3yr Pelvic Recurrence: 2.5% vs 2.2%."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š PAOLA-1", "type": "Published", "drug": "Olaparib + Bevacizumab", 
     "summary": "ä¸€ç·šç¶­æŒã€‚HRD+ æ—ç¾¤ 5å¹´ OS é¡¯è‘—æ”¹å–„ (HR 0.62)ã€‚ç¢ºç«‹çµ„åˆç¶­æŒè·¯å¾‘ã€‚",
     "results": "HRD+ OS HR 0.62; 5yr OS 75.2% vs 58.3%."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated", "HRD positive (wt)"], "name": "ğŸ“š ATHENAâ€“MONO", "type": "Published", "drug": "Rucaparib", 
     "summary": "ä¸€ç·šç¶­æŒã€‚ITT PFS HR 0.52ï¼›æ”¯æŒæ›´å»£æ³› PARPi æ‡‰ç”¨ã€‚",
     "results": "ITT PFS HR 0.52; HRD+ HR 0.47."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š NOVA", "type": "Published", "drug": "Niraparib ç¶­æŒ", 
     "summary": "å¾©ç™¼ç¶­æŒã€‚gBRCA (HR 0.27) èˆ‡é gBRCA (HR 0.45) å‡é¡¯è‘—æ”¹å–„ PFSã€‚",
     "results": "gBRCA HR 0.27; Non-gBRCA HR 0.45."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š ARIEL3", "type": "Published", "drug": "Rucaparib ç¶­æŒ", 
     "summary": "å¾©ç™¼ç¶­æŒã€‚åœ¨æ‰€æœ‰åˆ†å±¤ä¸­å‡æ”¹å–„ PFSã€‚æ”¯æŒäºŒç·šç¶­æŒã€‚",
     "results": "BRCAm HR 0.23; HRD+ HR 0.32."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š SOLO2", "type": "Published", "drug": "Olaparib (BRCA)", 
     "summary": "å¾©ç™¼ç¶­æŒ(BRCA)ã€‚é•·æœŸ OS æ”¹å–„ (51.7m vs 38.8m, HR 0.74)ã€‚",
     "results": "mOS 51.7m vs 38.8m; HR 0.74."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š DUO-O", "type": "Published", "drug": "Durva+Chemo+Bev", 
     "summary": "ä¸€ç·šã€‚HRD+ PFS é¡¯è‘—ç²ç›Š (HR 0.49)ã€‚IO çµ„åˆ PARPi ç­–ç•¥ä¹‹å¯¦è­‰ã€‚",
     "results": "HRD+ PFS HR 0.49."},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION (NEJM 2019)", "type": "Published", "drug": "No Lymphadenectomy", 
     "summary": "æ‰‹è¡“ã€‚å®Œå…¨åˆ‡é™¤ä¸”è‡¨åºŠ LN é™°æ€§è€…ï¼Œæ¸…æƒç„¡ç”Ÿå­˜ç²ç›Šä¸”ä½µç™¼ç—‡å¤šã€‚",
     "results": "OS HR 1.06 (P=0.65)."},
]

# --- 3. æ‹›å‹Ÿä¸­è©¦é©— (ğŸ“ Ongoing - 8 æ ¸å¿ƒè©³ç›¡ç´°ç¯€) ---
ongoing_trials = [
    {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)", "PSOC (Sensitive)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ FRÎ± ADCã€‚è¯ç”¨ Bevacizumab ç”¢ç”Ÿè¡€ç®¡é‡å¡‘å”åŒä½œç”¨ï¼Œæå‡è—¥ç‰©æ»²é€ä¸¦é€éæ—è§€è€…æ•ˆæ‡‰æ®ºå‚·ä½è¡¨é”ç´°èƒã€‚",
     "regimen": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚",
     "inclusion": ["High-grade Serous / Carcinosarcoma åµå·¢ç™Œã€‚", "ç¶“æª¢æ¸¬ç¢ºèª FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©å…§æƒ¡åŒ– (PROC)ã€‚"],
     "exclusion": ["æ›¾ç”¨é Topo I ADC (Enhertu)ã€‚", "å…·æœ‰è‡¨åºŠé¡¯è‘—è›‹ç™½å°¿ã€‚", "ILD ç—…å²ã€‚"], "results": "Phase 3 Recruitment ongoing."},

    {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCã€‚å…·å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ï¼Œå°ˆæ”»é«˜åº¦ç•°è³ªæ€§ä¸” CDH6 é«˜è¡¨é”ä¹‹ PROCã€‚",
     "regimen": "R-DXd 5.6mg/kg IV Q3Wã€‚",
     "inclusion": ["HG Serous æˆ– Endometrioid PROCã€‚", "å…ˆå‰æ¥å— 1-4 ç·šç³»çµ±æ²»ç™‚ã€‚", "æä¾›åˆ‡ç‰‡é€²è¡Œ CDH6 åˆ¤å®šã€‚"],
     "exclusion": ["Low-grade / Mucinous è…«ç˜¤ã€‚", "LVEF < 50%ã€‚", "åŸºç·šç¥ç¶“ç—…è®Š â‰¥ G2ã€‚"], "results": "ORR ~46% in Ph1 expansion."},

    {"cancer": "Ovarian", "name": "TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD positive (wt)", "HRD negative / pHRD"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°ä¹‹ ICD æ•ˆæ‡‰ï¼Œå„ªåŒ–ç¶­æŒéšæ®µç²ç›Šã€‚",
     "regimen": "Sac-TMT 5mg/kg Q3W + Bevacizumab ç¶­æŒã€‚",
     "inclusion": ["æ–°è¨ºæ–· FIGO Stage III/IV åµå·¢ç™Œã€‚", "HRD ç‹€æ…‹ç”±ä¸­å¤®å¯¦é©—å®¤åˆ¤å®šã€‚", "1L å«é‰‘åŒ–ç™‚å¾Œé” CR/PRã€‚"],
     "exclusion": ["BRCA çªè®Šã€‚", "å…ˆå‰ç”¨é Trop-2 ADCã€‚"], "results": "Phase 3 ongoing."},

    {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["IO Maintenance"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ã€‚é€éå…ç–«èª¿ç¯€å¼·åŒ– Pembrolizumab åœ¨ pMMR æ—ç¾¤çš„é•·æœŸæ‡‰ç­”ã€‚",
     "regimen": "Pembrolizumab 400mg Q6W + Sac-TMT 5mg/kg Q6Wã€‚",
     "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚"],
     "exclusion": ["å­å®®è‚‰ç˜¤ (Sarcoma)ã€‚", "å…ˆå‰é‡å°æ™šæœŸç—…ç¶é€²è¡Œéç³»çµ± IOã€‚"], "results": "Phase 3 recruiting."},
]

# --- 4. å‹•æ…‹æ¨¡å‹å·¡é‚èˆ‡ AI æ¨¡å‹é¸æ“‡ ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = None
        for m in available_models:
            if 'gemini-1.5-flash' in m: target_model = m; break
        if not target_model:
            for m in available_models:
                if 'gemini-pro' in m or 'gemini-1.5-pro' in m: target_model = m; break
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 5. å´é‚Šæ¬„ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = milestone_db[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ ç—…æ­·æ·±åº¦æ•¸æ“šæ¯”å°", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­· (å«ç´°èƒå‹æ…‹/æ¨™è¨˜)", height=250)
        if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    if model:
                        prompt = f"åˆ†æï¼š{p_notes}ã€‚åƒè€ƒé‡Œç¨‹ç¢‘ï¼š{milestone_db} åŠé€²è¡Œä¸­ï¼š{ongoing_trials}ã€‚æä¾›æœ€ä½³è·¯å¾‘ã€‚"
                        st.write(model.generate_content(prompt).text)
                    else: st.error("æ‰¾ä¸åˆ°å¯ç”¨ AIã€‚")
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 6. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 å¯¦è­‰èˆ‡æ”¶æ¡ˆå…¨æ•´åˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # A. é¡¯ç¤ºé‡Œç¨‹ç¢‘ (ğŸ“š)
            rel_milestones = [m for m in milestone_db if m["cancer"] == cancer_type and m["pos"] == stage["id"] and any(s in sub["title"] for s in m["sub_pos"])]
            for m in rel_milestones:
                with st.popover(f"ğŸ“š {m['name']}", use_container_width=True):
                    st.success(f"**æ‘˜è¦:** {m['summary']}")
                    if st.button("ğŸ“Š è©³ç´°ç´°ç¯€è¨è«–", key=f"btn_milestone_{m['name']}"):
                        st.session_state.selected_trial = m['name']
            
            # B. é¡¯ç¤ºæ‹›å‹Ÿä¸­ (ğŸ“)
            rel_trials = [t for t in ongoing_trials if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"ğŸ“ {t['pharma']} | {t['name']}"
                ukey = f"btn_ongoing_{t['name']}_{stage['id']}"
                with st.popover(label, use_container_width=True):
                    st.info(f"**Regimen:** {t['drug']}")
                    if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
                        st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 7. æ·±åº¦æ•¸æ“šçœ‹æ¿ ---
st.divider()
st.subheader("ğŸ“‹ è‡¨åºŠè©¦é©—æ·±åº¦æ•¸æ“šåº« (è«‹ç”±æ­¤é»é¸æˆ–åˆ‡æ›)")
all_list = milestone_db + ongoing_trials
selected_name = st.selectbox("ğŸ¯ é¸æ“‡è¦æŸ¥çœ‹çš„ç ”ç©¶è¨ˆç•«ï¼š", [t["name"] for t in all_list if t["cancer"] == cancer_type], index=0)
t = next(it for it in all_list if it["name"] == selected_name)

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦æ•¸æ“šåˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

r1, r2 = st.columns([1.3, 1])
with r1:
    st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Regimen (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
    st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
    st.write(f"**çµ¦è—¥æ–¹æ¡ˆ:** {t.get('regimen', t.get('dosing', 'è©³è¦‹ Protocol'))}")
    st.success(t['rationale'])

with r2:
    st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Key Outcomes (æœ€æ–°å¯¦è­‰æ•¸æ“š)</b></div>", unsafe_allow_html=True)
    st.markdown(f"""
        <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
            <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Survival Metrics / NCT</div>
            <div class='hr-big-val'>{t.get('results', 'Ongoing')}</div>
        </div>
    """, unsafe_allow_html=True)

st.divider()
r3, r4 = st.columns(2)
with r3:
    st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¢ä»¶)</b></div>", unsafe_allow_html=True)
    for inc in t.get('inclusion', []): st.write(f"â€¢ **{inc}**")
with r4:
    st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¢ä»¶)</b></div>", unsafe_allow_html=True)
    for exc in t.get('exclusion', []): st.write(f"â€¢ **{exc}**")
st.markdown("</div>", unsafe_allow_html=True)
